Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas

Br J Haematol. 2009 Apr;145(2):255-7. doi: 10.1111/j.1365-2141.2008.07565.x. Epub 2009 Feb 23.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Hepacivirus*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / virology
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a